Tyra Biosciences, Inc.
TYRA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001863127
In the last 90 days, Tyra Biosciences, Inc. insiders filed 1 open-market purchase and 0 sales; 168 institutions reported holding it in 13F filings for Q2 2026, worth $2.22B in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Tyra Biosciences, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 26 | 45 | +19 |
| Shares | 26.1M | 35.2M | +9.09M (+34.9%) |
| Value | $456.8M | $494.2M | +$37.4M (+8.2%) |
New holders (28)
Institutions that held Tyra Biosciences, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
Sold out (9)
Institutions that held Tyra Biosciences, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Deerfield Management Company, L.P. (Series C) | 625,000 | $11.0M |
| Jennison Associates LLC | 468,750 | $8.24M |
| Goldman Sachs Group Inc | 207,283 | $3.65M |
| LMR Partners LLP | 54,000 | $950.0K |
| Pinz Capital Management, LP | 27,700 | $487.0K |
| Samson Rock Capital LLP | 15,267 | $269.0K |
| Qube Research & Technologies Ltd | 11,456 | $202.0K |
| Maven Securities LTD | 10,140 | $178.0K |
| Red Tortoise LLC | 212 | $2.00K |